Skip to content

Role of Sweetness in Glucose Regulation

Role of Sweet Taste Signaling in Glucose Regulation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03844230
Acronym
STS
Enrollment
80
Registered
2019-02-18
Start date
2019-04-24
Completion date
2022-12-31
Last updated
2021-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

sweeteners, glucose metabolism, taste receptors, sucralose

Brief summary

Data from several studies show that consuming a diet high in low-calorie sweeteners (LCS), mainly in diet sodas, is linked to the same metabolic disorders as consuming a diet high in added sugars, including an increased risk of developing type 2 diabetes. Sweet taste receptors, once thought to be unique to the mouth, have now been discovered in other parts of the body, including the intestine and the pancreas, where they play a role in blood sugar control. These newly identified receptors provide new avenues to explore how LCS may affect metabolism and health. This project is designed to examine the role of sweet taste signaling, both in the mouth and in the gut, on blood sugar control and how habitual consumption of LCS may affect sweet taste signaling and metabolism in people with obesity.

Detailed description

The overall goal of this research is to assess the role of oral and gut sweetness signaling in postprandial glucose metabolism and to determine how acute and chronic low-calorie sweetener (LCS) consumption may affect this signaling in people with obesity. The aims will determine the independent and combined contributions of pharmacological inhibition (Aim 1) or extra stimulation (Aim 2) of sweet taste signaling in the gut, mouth, or both on hormonal responses to an oral glucose tolerance test (OGTT) in two groups of subjects with obesity: habitual and non-habitual LCS consumers. Validated sensory evaluation techniques will also ascertain subjects' taste perception (Aim 3) to test the hypotheses that habitual consumption of LCS blunts perception of sweetness and, in turn, affects postprandial glucose regulation.

Interventions

OTHERControl - Inhibition

Taste and spit up water 10 minutes before drinking a glucose load

OTHERExperimental I- Inhibition

Taste and spit up water 10 minutes before drinking a glucose load mixed with lactisole

OTHERExperimental II- Inhibition

Taste and spit up sucralose 10 minutes before drinking a glucose load mixed with lactisole

OTHERControl- Stimulation

Taste and spit up water 10 minutes before drinking a glucose load

OTHERExperimental I- Stimulation

Taste and spit up sucralose 10 minutes before drinking a glucose load

OTHERExperimental II- Stimulation

Drink sucralose 10 minutes before drinking a glucose load

Taste different solutions to evaluate sweet taste preference, suprathreshold intensity and detection threshold

Sponsors

Washington University School of Medicine
CollaboratorOTHER
University of Illinois at Urbana-Champaign
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* All races/ethnicities * Habitual (\> 5 diet sodas per week) and non-habitual (≤1 diet soda or 1 packet of LCS per week) LCS consumers * 30 ≤ BMI \<40 kg/m2 * Not severely insulin resistant (HOMA-IR2 \< 2.6)

Exclusion criteria

* BMI \< 30 and 40\< BMI kg/m2 * HOMA-IR2\>2.6 * Irregular LCS consumers (\>1 diet sodas or packets of LCS per week but \<5) * Current smokers or quit smoking nicotine cigarettes for less than 6 months ago * Pregnant, breastfeeding, menopausal * Presence of anemia : \<12g/dl for women and \<13g/dl for men * Blood donation in the past 8 weeks * Presence of malabsorption syndrome * History of bariatric surgery * Presence of inflammatory intestinal disease, liver or kidney disease * Have diabetes (fasting glucose level \>126mg/dl or plasma glucose level 2h after glucose challenge \>200 mg/dl) * Taking any medication that might affect glucose metabolism or the results of our study

Design outcomes

Primary

MeasureTime frameDescription
Plasma GlucoseUp to 5 hours after drinking a glucose loadBlood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma glucose concentration
Plasma InsulinUp to 5 hours after drinking a glucose loadBlood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma insulin concentration
Plasma C-PeptideUp to 5 hours after drinking a glucose loadBlood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma C-peptide concentration
Sensory EvaluationUp to 2 hoursParticipants will be tasting solutions containing different concentrations of glucose, sucrose and sucralose (some of the solutions will also have lactisole) to assess their detection threshold, sweet taste intensity and preference. They will have to rate the intensity of the solution on a general Labeled Magnitude Scale (gLMS) ranging from no sensation (0) to strongest imaginable sensation (100) and choose the solutions they prefer.

Countries

United States

Contacts

Primary ContactMarta Y Pepino, PhD
ypepino@illinois.edu(217) 300-2374
Backup ContactClara Salame, MSc, RD
csalame2@illinois.edu(217) 300-4709

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026